$ Value
$121K
Shares
1,799
Price
$68
Filed
May 19
Insider
Name
Flammer Martina M.D.
Title
Chief Medical Officer
CIK
0001796960
Roles
Transaction Details
Transaction Date
2025-05-16
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
84,797
Footnotes
Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. | Each RSU was granted on May 15, 2025 for no consideration. | This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. | This is the weighted average sales price representing 9,925 shares sold at prices ranging from $65.32 to $65.99 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. | These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.
Filing Info
Flammer Martina M.D.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-01 | INSM | M | $230K |
| 2025-12-01 | INSM | ▼ | $299K |
| 2025-12-01 | INSM | ▼ | $1.2M |
| 2025-12-01 | INSM | ▼ | $324K |
| 2025-12-01 | INSM | M | $0 |
| 2025-11-11 | INSM | M | $221K |
| 2025-11-11 | INSM | M | $346K |
| 2025-11-11 | INSM | ▼ | $1.0M |
| 2025-11-11 | INSM | ▼ | $2.3M |
| 2025-11-11 | INSM | ▼ | $2.0M |
Other Insiders at INSM (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Lewis William
Chair and CEO
|
— | $3.3M | 2026-04-16 |
|
Adsett Roger
Chief Operating Officer
|
— | $14.5M | 2026-04-01 |
|
Smith Michael Alexander
Chief Legal Officer
|
— | $3.0M | 2026-03-30 |